Radek
Kaczmarek/LinkedIn; Clive Smith/The Haemophilia Society
Aug 10, 2025, 06:59
WFH Throwback: WHO 25th Expert Committee Meeting on Selection and Use of Essential Medicines
World Federation of Hemophilia (WFH) recently shared on LinkedIn:
”Today, the WFH is participating in the WHO 25th Expert Committee Meeting on Selection and Use of Essential Medicines (EML).
Radek Kaczmarek, WFH CPSSA Committee Chair, and Clive Smith, WFH Volunteer and President of The Haemophilia Society, delivered a statement outlining critical updates needed to better align the EML with international clinical guidelines for hemophilia and von Willebrand Disease.”
Find the Statement and Call-to-Action presented at WHO Meeting by WFH, ISTH, EAHAD here.
The statement is also endorsed by the following organizations:
- American Society of Gene & Cell Therapy
- Asian-Pacific Society on Thrombosis and Hemostasis
- Association for Haemophilia and Allied Disorders-Asia Pacific
- European Haemophilia Consortium
- European Society for Gene and Cell Therapy
- Grupo Collectivo Latinoamericano de Hemostasis y Trombosis
- National Bleeding Disorders Foundation

Stay informed on the emerging in the field of bleeding disorders with Hemostasis Today.
-
Aug 26, 2026, 14:46Holly O’Byrne: A Framework for Developing and Managing Prehospital Blood Programs
-
Aug 26, 2026, 14:32Eleftherios Mylonakis: Earlier Intervention, Better Risk Stratification, Stronger BP Control
-
Aug 26, 2026, 14:32Bringing ISTH 2026 Research to the Global Scientific Community
-
Aug 26, 2026, 14:18Thomas Dayspring: Prognostic Impact of Lp(a) Changes Following Statin Therapy in Patients with CAD
-
Aug 26, 2026, 14:17Khurram Nasir: Are We Debating the Wrong Thing About Research in Medical Training?
-
Aug 26, 2026, 14:15Nathan Connell: Why Format Free Publishing Still Demands Formatting?
-
Aug 26, 2026, 14:14Reza Shojaei: China’s Reliance on Imported Albumin Raises Global Plasma Security Concerns
-
Aug 26, 2026, 14:03Ahmad Masri: The Amyloid Depleter Revolution in ATTR-CM
-
Aug 26, 2026, 13:59David McIntosh: Immunoglobulin Stewardship in the Face of Rising Demand